Evaluating a Our Practice Advisory (OPA) to Optimize Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH) Test Orders

Recruiting now · Not applicable

Conditions studied: Physician Workflow, Resource Utilization

In brief

Our Practice Advisory (OPA) are essential tools in clinical decision-making. The alerts are designed to guide providers towards evidence-based practices and improve patient outcomes. The focus of this initiative is on Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH) testing, with the goal of addressing unnecessary repeat testing within a 30-day timeframe, which rarely yields significant new insights. Although randomization occurs at the patient level, the primary outcome of this study focuses on provider behavior and decision-making. By focusing on this specific intervention, the study aims to optimize resource use, align test ordering with evidence-based guidelines, and support improved patient outcomes. The results of this evaluation will help refine OPAs and guide broader strategies for implementing clinical decision support tools across healthcare systems.

Key facts

Study ID

NCT06993805

Run by

University of California, Los Angeles

People needed

384

Starts

2025-05-06

Expected to finish

2026-02-01

Last updated by the study team

2025-05-29

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years or older
• Inpatient or observation stays within UCLA Health System hospitals
• Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH) ordered, AND this lab was ordered and resulted within the prior 30 days

You may not qualify if…

• Have an A1c or TSH ordered and do not have a result for one of these labs in the prior 30 days

Where it is running

• UCLA Health System — Los Angeles, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.